IL-17 and Th17 cells

Annual Review of Immunology

Volumn 27, Issue , 2009, Pages 485-517

  Korn, Thomas ^a   Bettelli, Estelle ^b   Oukka, Mohamed ^b   Kuchroo, Vijay K ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Cytokines; Effector T cells; Regulatory T cells; T cell differentiation; Tissue inflammation

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; DECTIN 1; EOTAXIN; FREUND ADJUVANT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; NUCLEIC ACID BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR ROR GAMMA T; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; ARTHRITIS; AUTOIMMUNITY; BACTEROIDES; BORRELIA; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL SELECTION; CITROBACTER RODENTIUM; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; ENTERITIS; GERMINAL CENTER; HOST RESISTANCE; HUMAN; IMMUNIZATION; IMMUNOREGULATION; KERATINOCYTE; KLEBSIELLA PNEUMONIAE; MEMORY CELL; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN EXPRESSION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; INTERLEUKINS; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 61949463911     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.021908.132710     Document Type: Review

References (224)

1. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-73
2. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-89
3. H17 and regulatory T cells. Nature 441:235-38
4. H17 lineage. Nature 441:231-34
5. H17 cells. Nature 448:484-87
6. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, et al. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:480-83
7. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967-74
8. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-48
9. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-40
10. + T helper cells. Cell 126:1121-33
11. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, et al. 2007. STAT3 regulates cytokinemediated generation of inflammatory helper T cells. J. Biol. Chem. 282:9358-63
12. Krakowski M, Owens T. 1996. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641-46
13. Tran EH, Prince EN, Owens T. 2000. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164:2759-68
14. Gran B, Zhang GX, Yu S, Li J, Chen XH, et al. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169:7104-10
15. Zhang GX, Gran B, Yu S, Li J, Siglienti I, et al. 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170:2153-60
16. Gutcher I, Urich E, Wolter K, Prinz M, Becher B. 2006. Interleukin 18-independent engagement of interleukin 18 receptor-α is required for autoimmune inflammation. Nat. Immunol. 7:946-53
17. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-25
18. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-41
19. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-32
20. Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480-86
21. Okuda Y, Sakoda S, Bernard CC, Fujimura H, Saeki Y, et al. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:703-8
22. Mendel I, Katz A, Kozak N, Ben-Nun A, Revel M. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1727-37
23. Eugster HP, Frei K, Kopf M, Lassmann H, Fontana A. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178-87
24. Boe A, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescenzi O. 1999. Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis. Cytokine 11:1057-64
25. Wei L, Laurence A, Elias KM, O'Shea JJ. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282:34605-10
26. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-49
27. Wilson NJ, Boniface K, Chan JR, McKenzie BS, BlumenscheinWM,et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950-57
28. H17 cells. Nature 454:350-52
29. Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9:641-49
30. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, et al. 2008. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating humanTH-17 responses. Nat. Immunol. 9:650-57
31. Li MO,Wan YY, Sanjabi S, Robertson AK, Flavell RA. 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24:99-146
32. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. 2006. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7:1151-56
33. Li MO, Wan YY, Flavell RA. 2007. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579-91
34. Lohr J, Knoechel B,Wang JJ,Villarino AV, Abbas AK. 2006. Role of IL-17 and regulatoryTlymphocytes in a systemic autoimmune disease. J. Exp. Med. 203:2785-91
35. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, et al. 2007. Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449:361-65
36. Wolk K, Kunz S, Asadullah K, Sabat R. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168:5397-402
37. Van Snick J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8:253-78
38. Taga T, Kishimoto T. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797-819
39. Kolls JK, Linden A. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-76
40. Kishimoto T. 2005. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23:1-21
41. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, et al. 2008.Thelper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity 28:29-39
42. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, et al. 2007. Cutting edge: an in vivo requirement for STAT3 signaling in Th17 development and Th17-dependent autoimmunity. J. Immunol. 179:4313-17
43. H17 cell differentiation by antagonizing RORγt function. Nature 453:236-40
44. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57-63
45. Leonard WJ, Spolski R. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688-98
46. Vinuesa CG, Tangye SG, Moser B, Mackay CR. 2005. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5:853-65
47. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, et al. 2004. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173:68-78
48. Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, et al. 2002. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells. J. Exp. Med. 196:969-77
49. + T cells. J. Exp. Med. 205:1369-79
50. King C, Ilic A, Koelsch K, Sarvetnick N. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265-77
51. Jain R, Tartar DM, Gregg RK, Divekar RD, Bell JJ, et al. 2008. Innocuous IFNγ induced by adjuvantfree antigen restores normoglycemia inNODmice through inhibition of IL-17 production. J. Exp. Med. 205:207-18
52. Fina D, Sarra M, Fantini MC, Rizzo A, Caruso R, et al. 2008. Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology 134:1038-48
53. Coquet JM, Chakravarti S, Smyth MJ, Godfrey DI. 2008. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180:7097-101
54. Sonderegger I, Kisielow J, Meier R, King C, Kopf M. 2008. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38:1833-38
55. Holmdahl R. 2008. IL-21 and autoimmune disease-hypothesis and reality? Eur. J. Immunol. 38:1800-2
56. Medvedev A, Chistokhina A, Hirose T, Jetten AM. 1997. Genomic structure and chromosomal mapping of the nuclear orphan receptor RORγ (RORC) gene. Genomics 46:93-102
57. He YW, Deftos ML, Ojala EW, Bevan MJ. 1998. RORγt, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9:797-806
58. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, et al. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103:8137-42
59. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL,Yu Q, et al. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 178:4901-7
60. Kimura A, Naka T, Kishimoto T. 2007. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl. Acad. Sci. USA 104:12099-104
61. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, et al. 2002. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 99:11808-12
62. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. 2002. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195:1003-12
63. Brustle A, Heink S, Huber M, Rosenplanter C, Stadelmann C, et al. 2007. The development of inflammatory TH-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8:958-66
64. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875-86
65. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-27
66. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29:44-56
67. DuJ, Huang C, Zhou B, Ziegler SF. 2008. Isoform-specific inhibition ofRORα-mediated transcriptional activation by human FOXP3. J. Immunol. 180:4785-92
68. Zhang F, Meng G, Strober W. 2008. Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9:1297-306
69. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371-81
70. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. 2007. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-60
71. + regulatory T cell homeostasis and the maintenance of self-tolerance. J. Immunol. 171:3435-41
72. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31:1637-45
73. + T cell numbers. J. Immunol. 169:4850-60
74. Malek TR,Yu A,Vincek V, Scibelli P, Kong L. 2002.CD4regulatoryTcells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17:167-78
75. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204:1765-74
76. + regulatory T cells via a TGF-β and retinoic aciddependent mechanism. J. Exp. Med. 204:1757-64
77. Kamanaka M, Kim ST,Wan YY, Sutterwala FS, Lara-Tejero M, et al. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25:941-52
78. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181:2277-84
79. + regulatory T cells. J. Immunol. 179:3724-33
80. Veldhoen M, Hirota K,Westendorf AM, Buer J, Dumoutier L, et al. 2008. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453:106-9
81. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, et al. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27:786-800
82. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65-71
83. Kastelein RA, Hunter CA, Cua DJ. 2007. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25:221-42
84. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. 2003. Interleukin-23 promotes a distinct CD4Tcell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-14
85. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, et al. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951-57
86. H-17 cell-mediated pathology. Nat. Immunol. 8:1390-97
87. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309-18
88. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203:1685-91
89. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, et al. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203:2473-83
90. Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, et al. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28:559-70
91. Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, et al. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:2485-94
92. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-63
93. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, et al. 2007. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80:273-90
94. Liu Y, Helms C, Liao W, Zaba LC, Duan S, et al. 2008. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4:e1000041
95. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:1107-17
96. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-46
97. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, et al. 2008. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 128:2640-45
98. H17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773-76
99. Goriely S, Neurath MF, Goldman M. 2008.Howmicroorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 8:81-86
100. Re F, Strominger JL. 2001.Toll-like receptor 2 (TLR2) andTLR4differentially activate human dendritic cells. J. Biol. Chem. 276:37692-99
101. Carmody RJ, Ruan Q, Liou HC, Chen YH. 2007. Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J. Immunol. 178:186-91
102. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW,Muller FJ, Hommes DW, et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660-69
103. Touil T, Fitzgerald D, Zhang GX, Rostami A, Gran B. 2006. Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-β. J. Immunol. 177:7505-9
104. Sheibanie AF,Tadmori I, Jing H,Vassiliou E, Ganea D. 2004. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18:1318-20
105. Schnurr M,ToyT, Shin A,Wagner M, Cebon J, Maraskovsky E. 2005. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105:1582-89
106. Leibundgut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, et al. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630-38
107. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. 2000. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165:6107-15
108. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-27
109. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 170:1958-63
110. + Tcell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-77
111. Rudner XL, Happel KI, Young EA, Shellito JE. 2007. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75:3055-61
112. Huang W, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-31
113. +CCR5-phenotype. J. Immunol. 178:7525-29
114. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, et al. 2007. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356:580-92
115. Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, et al. 2006. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 54:1122-31
116. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, et al. 1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5:101-4
117. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, et al. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430-38
118. Barczyk A, Pierzchala W, Sozanska E. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97:726-33
119. Pene J, Chevalier S, Preisser L, Venereau E, Guilleux MH, et al. 2008. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180:7423-30
120. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103:1345-52
121. Miranda-Carus ME, Benito-Miguel M, Balsa A, Cobo-Ibanez T, Perez de Ayala C, et al. 2006. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum. 54:1151-64
122. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203:2673-82
123. Koenders MI, Lubberts E, van de Loo FA, Oppers-Walgreen B, Van Den Bersselaar L, et al. 2006. Interleukin-17 acts independently of TNF-α under arthritic conditions. J. Immunol. 176:6262-69
124. Koenders MI, Lubberts E, Oppers-Walgreen B,VanDenBersselaar L, HelsenMM,et al. 2005. Induction of cartilage damage by overexpression ofTcell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 52:975-83
125. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500-8
126. Ishizu T, Osoegawa M, Mei FJ, Kikuchi H,Tanaka M, et al. 2005. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 128:988-1002
127. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, et al. 2007. HumanTH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13:1173-75
128. Vaknin-Dembinsky A, Balashov K, Weiner HL. 2006. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 176:7768-74
129. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, et al. 2007. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179:7791-99
130. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-79
131. Yang XO, Chang SH, Park H, Nurieva R, Shah B, et al. 2008. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205:1063-75
132. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, et al. 2007. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51
133. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, et al. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566-73
134. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-81
135. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, et al. 2005. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237:123-30
136. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, et al. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172:146-55
137. Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, et al. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179:8098-104
138. Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB. 2006. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 176:1908-15
139. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, et al. 2007. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122:201-6
140. Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, et al. 2002. Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci. 30:161-66
141. Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, et al. 2008. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J. Invest. Dermatol. 128:1653-61
142. Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, et al. 2008. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675-84
143. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, et al. 2008. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128:1207-11
144. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez Farinas M, et al. 2007. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204:3183-94
145. Hoeve MA, Savage ND, de Boer T, Langenberg DM, deWaal Malefyt R, et al. 2006. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 36:661-70
146. Zhang XJ, Yan KL, Wang ZM, Yang S, Zhang GL, et al. 2007. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J. Invest. Dermatol. 127:2544-51
147. Wolk K, Sabat R. 2006. Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17:367-80
148. Sa SM, Valdez PA, Wu J, Jung K, Zhong F, et al. 2007. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178:2229-40
149. Ma HL, Liang S, Li J, Napierata L, Brown T, et al. 2008. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118:597-607
150. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, et al. 2006. IL-23 is essential for T cellmediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116:1310-16
151. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70
152. Elson CO, Cong Y,Weaver CT, Schoeb TR, McClanahan TK, et al. 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359-70
153. Fuss IJ, Becker C, Yang Z, Groden C, Hornung RL, et al. 2006. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12:9-15
154. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-89
155. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110:55-62
156. Nakae S, Nambu A, Sudo K, Iwakura Y. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171:6173-77
157. RohnTA, Jennings GT, Hernandez M, Grest P, Beck M, et al. 2006.Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 36:2857-67
158. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, et al. 2007. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56:2957-67
159. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, et al. 2008. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118:205-16
160. + Th cells that cause autoimmune arthritis. J. Exp. Med. 204:41-47
161. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204:2803-12
162. Takagi R, Higashi T, Hashimoto K, Nakano K, Mizuno Y, et al. 2008. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J. Immunol. 181:186-89
163. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, et al. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52:1037-46
164. Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, et al. 2007. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 56:1152-63
165. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, et al. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761-69
166. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177:7980-89
167. Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9:78-86
168. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF Jr, et al. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 116:2044-55
169. Aggarwal S, Gurney AL. 2002. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71:1-8
170. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. 2004. IL-17 cytokine family. J. Allergy Clin. Immunol. 114:1265-73; quiz 74
171. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985-95
172. Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh CL, et al. 2007. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-β and interleukin-6. J. Leukoc. Biol. 82:354-60
173. Lockhart E, Green AM, Flynn JL. 2006. IL-17 production is dominated by γä T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662-69
174. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170:2106-12
175. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. 2005. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect. Immun. 73:935-43
176. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, et al. 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167:4137-40
177. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, et al. 1995. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811-21
178. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, et al. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol. 160:3513-21
179. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, et al. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GROα chemokine from mesothelial cells. J. Immunol. 165:5814-21
180. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, et al. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162:2347-52
181. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, et al. 1996.Tcell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593-603
182. Awane M, Andres PG, Li DJ, Reinecker HC. 1999. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162:5337-44
183. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP. 1999. Mitogen-activated protein kinase and nuclear factor κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinaseactivated protein kinase (MAPKAPK). Arthritis Rheum. 42:2399-409
184. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, et al. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20:5332-41
185. Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, et al. 2002. The structure of human macrophage inflammatory protein-3α/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human β-defensins. J. Biol. Chem. 277:37647-54
186. Moseley TA, Haudenschild DR, Rose L, Reddi AH. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155-74
187. Hsu HC, Yang P, Wang J, Wu Q, Myers R, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9:166-75
188. King C, Tangye SG, Mackay CR. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26:741-66
189. Kuestner RE, Taft DW,Haran A, Brandt CS, Brender T, et al. 2007. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179:5462-73
190. Toy D, Kugler D,Wolfson M, Vanden Bos T, Gurgel J, et al. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177:36-39
191. Gratchev A, Kzhyshkowska J, Duperrier K, Utikal J, Velten FW, Goerdt S. 2004. The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells. Scand J. Immunol. 60:233-37
192. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, et al. 2001. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276:1660-64
193. Rickel EA, Siegel LA, Park Yoon B-R, Rottman JB, Kugler DG, et al. 2008. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181:4299-310
194. Shalom-Barak T, Quach J, Lotz M. 1998. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J. Biol. Chem. 273:27467-73
195. Schwandner R, Yamaguchi K, Cao Z. 2000. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191:1233-40
196. Chang SH, Park H, Dong C. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281:35603-7
197. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8:247-56
198. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, et al. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109:3794-802
199. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, et al. 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73:617-21
200. TanW, Huang W, Zhong Q, Schwarzenberger P. 2006. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J. Immunol. 176:6186-93
201. Molesworth-Kenyon SJ, Yin R, Oakes JE, Lausch RN. 2008. IL-17 receptor signaling influences virusinduced corneal inflammation. J. Leukoc. Biol. 83:401-8
202. Dubin PJ, Kolls JK. 2007. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L519-28
203. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451:211-15
204. Dumoutier L, Louahed J, Renauld JC. 2000. Cloning and characterization of IL-10-related T cellderived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164:1814-19
205. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, et al. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275:31335-39
206. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, et al. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 276:2725-32
207. Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL. 2001. Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 21:1047-53
208. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, et al. 2002. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J. Biol. Chem. 277:47517-23
209. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277:33676-82
210. Brand S, Dambacher J, Beigel F, Zitzmann K, Heeg MH, et al. 2007. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G1019-28
211. Dumoutier L, Lejeune D, Colau D, Renauld JC. 2001. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J. Immunol. 166:7090-95
212. Wei CC, Ho TW, Liang WG, Chen GY, Chang MS. 2003. Cloning and characterization of mouse IL-22 binding protein. Genes Immun. 4:204-11
213. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, et al. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36:1309-23
214. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647-59
215. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, et al. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534-44
216. Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, et al. 2006. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J. Immunol. 177:3635-43
217. Wolk K, Witte E, Hoffmann U, Doecke WD, Endesfelder S, et al. 2007. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J. Immunol. 178:5973-81
218. + T cells. Immunity 16:779-90
219. Villarino AV, Huang E, Hunter CA. 2004. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 173:715-20
220. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929-36
221. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-45
222. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, et al. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8:1363-71
223. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, et al. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8:1380-89
224. Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, et al. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8:1372-79